Paid clinical trials and research studies with broad eligibility and compensation of $500 or more, plasma donation pay, bonus and eligibility changes at the national chains, blood shortage appeals with incentives, paid survey and usability study programs from established firms, study enrollment and donor safety rule changes, with the sponsor or chain first and the pay stated.